Typhoid vaccine - Vaxine
Latest Information Update: 03 Mar 2023
At a glance
- Originator Vaxine
- Developer Matrivax; Vaxine
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Typhoid
Most Recent Events
- 06 Feb 2023 Preclinical trials in Typhoid (Prevention) in Australia (Prior to February 2023) (Vaxine pipeline, February 2023)
- 06 Feb 2023 Preclinical trials in Typhoid (Prevention) in USA (Prior to February 2023) (Vaxine pipeline, February 2023)